For those of us who weren't paying attention, over the last few years, scientists around the world have been one-upping each other in a bid to create the smallest QR code that can be reliably read.

Booster vaccines reduced the risk of COVID‑19–related hospitalization and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research led by the ...

Just how small can a QR code be? Small enough that it can only be recognized with an electron microscope. A research team at TU Wien, working together with the data storage technology company Cerabyte ...

The U.S. bans Chinese software in connected cars starting March 17, forcing automakers to purge code fast. Could this stall Chinese brands in America? Automakers must remove Chinese-written code from ...

Discovering how potato starch and skin look like under a microscope. Warnings issued on nationalizing elections, ICE at polls — "Huge danger" Amazon pulls 'Melania' after theater mocks film on marquee ...

Pfizer beat on 2025 sales and beat on earnings -- but still delivered a loss. Pfizer reaffirmed 2026 sales and earnings guidance for under $3 per share. Analysts forecast the pharmaceuticals giant ...

Bayer has filed separate lawsuits against the creators of three COVID-19 vaccines, claiming they violated intellectual property developed by Monsanto, the crop science company the German company ...

A Moderna spokesperson said the company is aware of the lawsuit and will defend itself. Spokespeople for Pfizer, BioNTech and Johnson & Johnson did not immediately respond to requests for comment.

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A box of Moderna Spikevax (COVID-19 Vaccine, mRNA) is kept in the refrigerator at Skippack Pharmacy in Schwenksville, ...

Pfizer has been struggling for several years. The company's pipeline could help it turn things around. It also has a solid dividend program and is attractively valued. Trading at a bit under $25 ...

Pfizer stock has been a weak performer, declining by about 7% through 2025. Things could remain mixed over 2026 as well, with the company guiding for revenues of $59.5-$62.5 billion and adjusted EPS ...

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) announced the closing of its acquisition of CureVac N.V. (NASDAQ:CVAC), which ...